Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gloria Fuentes
Synergy Between Trastuzumab and Pertuzumab for Human Epidermal Growth Factor 2 (Her2) From Colocalization: An in Silicobased Mechanism
Breast Cancer Research
Cancer Research
Oncology
Related publications
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab With Taxane for Human Epidermal Growth Factor Receptor 2–positive Advanced Breast Cancer: Final Results From MARIANNE
Cancer
Cancer Research
Oncology
Pertuzumab and Trastuzumab: The Rationale Way to Synergy
Anais da Academia Brasileira de Ciencias
Multidisciplinary
Pertuzumab in Human Epidermal Growth-Factor Receptor 2-Positive Breast Cancer: Clinical and Economic Considerations
International Journal of Women's Health
Gynecology
Oncology
Midwifery
Maternity
Obstetrics
Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Human Epidermal Growth Factor 2 (HER2) Non-Small Cell Lung Cancer (NSCLC) With YVMA Mutation Responsive to Ado-Trastuzumab Emtansine
Journal of Case Reports and Images in Oncology
FEN1 Knockdown Improves Trastuzumab Sensitivity in Human Epidermal Growth Factor 2‑positive Breast Cancer Cells
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Correction: Cryo-Em Structure of HER2-trastuzumab-pertuzumab Complex
PLoS ONE
Multidisciplinary
Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization
Molecular Cancer Therapeutics
Cancer Research
Oncology
Ado-Trastuzumab Emtansine Targets Hepatocytes via Human Epidermal Growth Factor Receptor 2 to Induce Hepatotoxicity
Molecular Cancer Therapeutics
Cancer Research
Oncology
